nterococci are Gram-positive bacteria that generally colonize the gastrointestinal tracts of animals. They are also found in food, water, and environmental samples. Enterococci were once considered harmless commensals of humans, but they have emerged as important nosocomial pathogens over the past 3 decades. Enterococcus spp., especially Enterococcus faecalis and Enterococcus faecium, are now the second major cause of surgical and urinary tract infections and the third major cause of bacteremia (1) . The ability of Enterococcus spp. to acquire mobile genetic elements, such as plasmids and transposons carrying the determinants of antimicrobial resistance and virulence, has contributed to their emergence as often multiresistant pathogens. Antimicrobial multiresistance drastically limits the therapeutic options in the treatment of infections, and the emergence and rapid spread of glycopeptide-resistant enterococci has presented a particular challenge, since there are few remaining options for antimicrobial treatment (2) . As donors and recipients of antimicrobial resistance genes, Enterococcus spp. play an important role in the dissemination of resistance genes by horizontal gene transfer. The transmission of the vanA gene cluster-carrying transposon Tn1546 from vancomycin-resistant enterococci (VRE) to methicillin-resistant Staphylococcus aureus (MRSA), creating a vancomycin-and methicillin-resistant S. aureus strain in a hospitalized patient, represents a dramatic example of this phenomenon (3) .
As the first oxazolidinone introduced for clinical use in the United States since 2000 and in China since 2007, linezolid is currently the most efficient antimicrobial against VRE, MRSA, and penicillin-resistant pneumococci (4) . As a last-resort antimicrobial agent, linezolid not only exhibits strong antibacterial activity but also has properties that mitigate against the development of drug resistance in bacteria (5) . No evidence of a significant increase in the percentage of linezolid-resistant bacteria has been reported in the LEADER Program, whose results are available on an annual basis since 2006 (6) . The most recent results from the LEADER Program for the year 2009 reported an overall percentage of linezolid resistance of 0.34% (6) . The most common mechanism of linezolid resistance involves mutations in the central loop of domain V of 23S rRNA, with G2576T (Escherichia coli numbering) being the most frequent mutation (7), followed by mutations in the genes for the ribosomal proteins L3 and L4 (8) . Transferable linezolid resistance is due to the gene cfr encoding an rRNA methyltransferase which methylates position 8 of A2503 (9) and inhibits ribose methylation at nucleotide C2498 in the 23S rRNA (10) . Thereby, Cfr confers resistance to five chemically unrelated antimicrobial classes including phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A (11) and decreased susceptibility to the 16-membered macrolides spiramycin and josamycin (12) .
The observation that the gene cfr is often located on plasmids underlines the potential for the spread of this gene (11) . Although it was initially discovered on the 17.1-kb multiresistance plasmid, pSCFS1, in a bovine Staphylococcus sciuri isolate (13), the gene cfr has been detected in seven bacterial genera, including Staphylococcus, Bacillus, Enterococcus, Macrococcus, Jeotgalicoccus, Proteus, and Escherichia. Most of the corresponding isolates were derived from domestic animals (mainly pigs) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) , and plasmids seemed to play an important role in the interspecies and intergenus transfer of the cfr gene. To date, 17 different cfr-carrying plasmids have been reported (Table 1) . Among these plasmids, only the staphylococcal plasmids pSCFS7 and pERGB and the enterococcal plasmid pHOU-cfr were characterized as conjugative plasmids (14, 25, 27) . In the present study, we describe three transferable multiresistance plasmids obtained from Enterococcus spp. from domestic pigs and farm environments which carry the cfr gene in new genetic environments.
MATERIALS AND METHODS

Bacterial isolates and detection of florfenicol resistance genes. A total of 77 Enterococcus isolates (E. faecalis
, and Enterococcus sp. strain CIFRI D-TSB15 [n ϭ 1]) with florfenicol MIC values of Ն16 g of were/ml collected from individual pigs (n ϭ 65; 57 from rectal swabs and 8 from nasal swabs), pig farm environments (n ϭ 9; 8 from sewage and 1 from soil), and farm workers (n ϭ 3; all from rectal swabs) in three pig farms and one slaughterhouse in Shandong province in 2011. Although no clinical breakpoints for florfenicol applicable to enterococci are currently available, isolates with an MIC of Ն16 g of were/ml tentatively considered as florfenicol resistant. Whole-cell DNA from the Enterococcus isolates was extracted using a commercial kit (TianGen, Beijing, China) according to the manufacturer's instructions. The presence of the florfenicol resistance genes cfr, fexA, and fexB was investigated using previously described methods (28, 30) .
Molecular typing. Pulsed-field gel electrophoresis (PFGE) was performed to investigate the clonality of the cfr-positive enterococcus isolates. DNA preparation and subsequent restriction analysis were conducted as described previously (31) . Whole-cell DNA was incubated with SmaI (TaKaRa, Dalian, China) for 6 h at 30°C. The resulting restriction fragments were separated using a CHEF-DRIII system (Bio-Rad) with a clamped homogeneous electric field of 6 V/cm, using a 120°switch angle for 16 h at 14°C, with the pulse time linearly ramped from 1 s to 20 s. The cfr-positive bovine E. faecalis isolate EF-01, which was the first Enterococcus isolate of animal origin carrying the cfr gene (17) , was included for comparison. In addition, typing of the cfr-positive E. faecalis isolates was performed by multilocus sequence typing (MLST), using an established set of MLST primers described previously (32) .
Filter mating. Filter mating was performed with each of the three cfr-positive original isolates using E. faecalis JH2-2 (rifampin resistance) as the recipient, following the method described previously (33) . The concentrations of antibiotics in brain heart infusion agar plates used for the selection of transconjugants were 25 g/ml for rifampin and 10 g/ml for florfenicol. Transconjugants were confirmed as cfr positive and fexA and fexB negative by PCR analysis; PFGE was also performed in all transconjugants using SmaI to confirm that they were derivatives of the recipient strain JH2-2.
Antimicrobial susceptibility testing. The MICs of all of the cfr-positive original Enterococcus isolates, transconjugants, and E. faecalis JH2-2 were determined using broth microdilution according to the recommendations of documents M31-A3 (34) and M100-S21 (35) of the Clinical and Laboratory Standards Institute. The reference strain E. faecalis ATCC 29212 served as a quality control.
Analysis of cfr-carrying plasmids. To estimate the size of the cfrcarrying plasmids, whole-cell DNA of the enterococcal isolates in agarose gel plugs were treated with S1 nuclease (TaKaRa) and then separated by PFGE as described previously (36, 37) ; gels were run for 14 h. Plasmid DNA was extracted using a plasmid extraction midi kit (Qiagen, Germany) using a modification described previously (17) . The extracted plasmids and S1 nuclease-linearized PFGE-separated plasmid DNA fragments were transferred to Hybond Nϩ membranes (Amersham Biosciences, USA) and hybridized with digoxigenin (DIG)-labeled cfr-, fexA-, or fexB-specific probes. The DIG High Prime DNA Labeling and Detection Starter Kit I (Roche Applied Sciences, Germany) was used for detection. The regions flanking the cfr gene were sequenced by a modified random primer sequencing walking strategy, as previously described (38) . To determine the stability of the ISEnfa4 flanked segments in plasmids in both the original strains and in the transconjugants, inverse PCR was performed using the primers cfrIF and cfrIR (these are complementary to locations inside the cfr gene) (22) .
Nucleotide sequence accession numbers. The nucleotide sequences of a 27,360-bp segment of plasmid pW3, a 21,116-bp fragment of p3-38, and a 25,761-bp segment of pW9-2 have been deposited in GenBank under accession numbers JQ911739 (pW3), JQ911740 (p3-38), and JQ911741 (pW9-2), respectively.
RESULTS
Identification of the florfenicol resistance genes cfr, fexA, and fexB in Enterococcus isolates. PCR analysis of whole-cell DNA with primers specific for the three florfenicol resistance genescfr, fexA, and fexB-thus far identified in Enterococcus demonstrated that these genes were present alone or in different combinations in most of the isolates included in the present study. Of the 77 enterococci studied, 68 isolates carried either fexA (n ϭ 36), fexB (n ϭ 14), or both genes (n ϭ 18); only two isolates (E. thailandicus 3-38 and E. faecalis W9-2) carried both cfr and fexA, whereas only one isolate (E. thailandicus W3) carried both cfr and fexB. Interestingly, six isolates did not harbor any of these genes. Of the three cfr-positive isolates, E. thailandicus 3-38 was collected from a rectal swab of a pig, whereas E. thailandicus W3 and E. faecalis W9-2 were collected from sewage at a different pig farm. The nucleotide sequences of the amplified cfr genes in these three strains were 100% identical to the cfr gene of the S. sciuri plasmid pSCFS1 (accession number NC_005076). The 977-bp fexA amplicon from E. faecalis W9-2 was identical to the corresponding fexA sequence of the S. aureus plasmid pSCFS7 (FN995110), whereas a single nucleotide exchange (T¡A) at position 551 was detected in the fexA amplicon of E. thailandicus 3-38R, which caused an amino acid change at position 71 of the phenicol exporter protein (Phe¡Ile). Finally, the 786-bp fexB amplicon obtained from E. thailandicus W3 was identical to fexB from plasmid pEFM-1 (JN201336) of E. faecium. Antimicrobial resistance, clonality, and plasmid profiles of the cfr-positive enterococci isolates. All three cfr-positive isolates exhibited resistance to chloramphenicol, erythromycin, tetracycline, ciprofloxacin, and rifampin and had elevated MICs against florfenicol (up to 64 to 128 g/ml) but were susceptible to ampicillin and vancomycin. In addition, the MICs for linezolid were 8 g/ml (E. thailandicus 3-38) and 4 g/ml (E. thailandicus W3 and E. faecalis W9-2) ( Table 2 ). PFGE analysis of the four cfr-positive Enterococcus isolates, including the previously described bovine cfr-carrying E. faecalis isolate EF-01, revealed marked genomic heterogeneity of less than 65% similarity in their SmaI patterns (Fig. 1A) . MLST of E. faecalis EF-01 indicated that it belongs to ST21 within the clonal complex 21 (CC21) (39) , whereas E. faecalis W9-2 represented the novel ST type ST469.
Conjugation proved successful using isolates W3, 3-38, and W9-2 as the donor strains and JH2-2 as the recipient strain; three transconjugants, designated JHW3, JH3-38 and JHW9-2, respectively, were obtained. The sizes of the plasmids present in the original strains and their transconjugants were determined by S1 nuclease-PFGE. Each of the original strains harbored at least three plasmids, but at least one visible plasmid band could be observed in each of the three transconjugants (Fig. 1B) . Southern blot analysis showed that the cfr probe hybridized to a band of ϳ75 kb in both W3 and JHW3, a band of ϳ72 kb in both 3-38 and JH3-38, and a band of ϳ55 kb in both W9-2 and JHW9-2 (Fig. 1C) ; these three cfr-carrying plasmids were designated pW3, p3-38 and pW9-2, respectively. In addition, we confirmed that the florfenicol exporter gene fexA was not associated with any of the plasmids in E. thailandicus 3-28 and located on an ϳ40-kb plasmid in E. faecalis W9-2, while the fexB gene was located on an ϳ50-kb plasmid in E. thailandicus W3 (data not shown).
MIC testing revealed that all transconjugants exhibited at least 4-fold-elevated MICs for chloramphenicol, florfenicol, and linezolid compared to the recipient JH2-2 strain. No observable MIC changes were found for tetracycline and ciprofloxacin. Interestingly, all transconjugants showed 32-fold elevated MICs for erythromycin, compared to JH2-2 ( Table 2) . PCR screening to detect erythromycin resistance genes using previously described primers (40, 41) revealed the presence of the erm(B) gene in transconjugants JHW3 and JHW9-2 and their original strains, while the erm(A) gene was detected in both JH3-38 and 3-38. The erm(B) gene in pW3 and pW9-2 encode a 245-amino-acid (aa) rRNA methylase that shares 100% identity with Erm(B) from Streptococcus suis D12 (AER19841), and the Erm(B) protein differs by only four aa exchanges (S100N, H163Y, H217Y, and N222D) from that from pAM␤1 (ACY79534). The 571-bp erm(A) amplicon from Analysis of the genetic environment of cfr in the conjugative plasmids pW3, p3-38, and pW9-2. To gain insight into the genetic environment of the cfr gene in the three newly identified conjugative plasmids, cfr-carrying segments of 27,360, 21,116, and 25,550 bp of the ϳ75-kb plasmid pW3, the ϳ72-kb plasmid p3-38, and the ϳ55-kb pW9-2 plasmid, respectively, were sequenced. The corresponding maps are shown in Fig. 2 .
All three segments had an overall nucleotide sequence identity of Ͼ96% with respect to each other. The 4,447-bp central region, including cfr and the two 1,324-bp insertion sequences located in the same orientation, even displayed 100% nucleotide sequence identity. The further flanking sequences in pW3, p3-38, and pW9-2 exhibited a high nucleotide sequence identity (Ͼ95%) to the corresponding regions of the conjugative plasmid pAM␤1 (GU128949) from E. faecalis (Fig. 2) .
In the cfr upstream region, the putative promoter and the partly overlapping reading frames for peptides of 59 aa (ORF1) and 44 aa (ORF2) were present. However, in comparison to pSCFS1, a 51-bp deletion had occurred in ORF1 which resulted in the loss of the first 17 aa of ORF1. This deletion was also present in the cfr upstream region of pEF-01 from bovine E. faecalis (17) but differed from the 35-bp deletion in the region between the stop codon of ORF2 and the start codon of cfr in the staphylococcal plasmid pSCFS3 (16) . Two copies of a 1,324-bp insertion sequence harboring a 1,173-bp transposase gene and imperfect 26-bp terminal inverted repeats were found. These insertion sequences are most closely related to IS1542 from E. faecium with an overall nucleotide sequence identity of 91.6% (1,213/1,324 bp) and 93.8% aa sequence identity (366/390 aa) in the transposase protein (42) . This insertion sequence was submitted to the IS database (http://www-is.biotoul.fr/is.html) and received the designation ISEnfa4. Except for an 823-bp sequence, including the orf1 located downstream of the cfr gene on pSS-01, the 4,447-bp central region shared Ͼ99% nucleotide identity with the corresponding region of plasmid pSS-01 (accession no. JQ041372) present in S. cohnii and S. saprophyticus (Fig. 3) .
Immediately upstream of the righthand ISEnfa4 element and downstream of the left-hand ISEnfa4 element in the 4,447-bp central region, two different 8-bp direct repeats (DR) at the integration site were observed in the three conjugative plasmids. One DR (5=-TAGAATCA-3=), located in the open reading frame of AM16 (which exhibited Ͼ99% nucleotide [304/306 bp] identity to that in pAM␤1), was found in the E. faecalis plasmid pW9-2. The other DR (5=-GAAATTGA-3=), located in a noncoding region between the genes AM15 and AM17, was found in both E. thailandicus plasmids pW3-1 and p3-38. It should be noted that the AM16 gene could not be detected in these two plasmids (Fig. 3) . To determine the stability of the ISEnfa4 flanked segment in the three conjugative plasmids, inverse PCR assays were performed using cfrIF and cfrIR primers. Amplicons 3,123 bp in size were obtained from each of the three parental strains and their transconjugants. Sequence analysis of these amplicons confirmed that they contained an intact cfr gene region and one complete ISEnfa4 element.
DISCUSSION
Since only little a information is currently available about the presence of the multiresistance gene cfr among enterococci of animal origin (17), we screened 77 enterococcal isolates for the presence of this gene. The detection of the cfr gene in 3 of 77 (3.9%) florfenicol-resistant enterococcus strains of swine and farm environmental origin suggested that this multiresistance gene is relatively rare among enterococci from pig farms in Shandong Province, China. To the best of our knowledge, this is the first report of the cfr gene in the species E. thailandicus. E. thailandicus is a newly discovered enterococcal species, which was initially isolated from fermented sausage in Thailand (43) . To date, no clinical E. thailandicus isolate has been reported; however, two strains of Enterococcus sanguinicola, which in the meantime have been reclassified as E. thailandicus, were recovered from clinically relevant human sources (44) . The presence of the cfr gene in E. thailandicus from swine and sewage origins points toward the presence of this multiresistance gene in enterococci from animal settings and the surrounding environment. The predominant resistance gene among florfenicol-resistant enterococci was fexA, which was detected in 72.7% (56/77) of the isolates tested in the present study; this finding was similar to the percentage of fexA-positive isolates among florfenicol-resistant staphylococci of swine origin (73.2%, 109/149) (22) . In addition, the recently identified florfenicol exporter gene fexB was detected in 41.6% (32/77) of the isolates tested in the present study. The coexistence of fexA and fexB in the same isolate was also observed in 18 (23.4%) of the strains tested. In addition, 7.8% (6/77) of the florfenicol-resistant isolates examined here did not harbor any of the three genes cfr, fexA, or fexB, which suggests that potential nonenzymatic or enzymatic mechanisms conferred by other, asyet-identified resistance genes might be involved in florfenicol resistance in enterococci.
The different SmaI PFGE patterns observed suggested that the three porcine and the single bovine cfr-positive enterococcal isolates are not related. Furthermore, MLST of two cfr-carrying E. faecalis strains originating from swine and cattle in China revealed that one of these isolates (EF-01) belongs to ST21, and the other (W9-2) represents the novel type ST469. The E. faecalis EF-01 isolate, which belonged to the clonal complex CC21, is mainly found in animals and in the community, while clinical isolates of this CC have rarely been detected (45) . Concerning the W9-2 isolates, the ST469 belongs to a singleton, which did not have single or double locus variants by performing an eBURST analysis (data not shown).
In the present study, three different types of large cfr-carrying conjugative enterococcal plasmids-pW3, p3-38, and pW9-2-could be differentiated on the basis of their sizes, their additional erythromycin resistance genes, and the sequences surrounding the cfr gene. Despite these differences, high structural similarities between these three plasmids and plasmid pAM␤1 were observed. Plasmid pAM␤1, a member of a family of low-copy-number conjugative plasmids (46) , was originally identified in a E. faecalis DS5 clinical isolate that harbored the MLS B resistance gene erm(B) (47) and could be transferred to, and maintained in, a wide range of Gram-positive bacteria (e.g., enterococci, streptococci, S. aureus, Bacillus subtilis, and some Lactobacillus casei strains), indicating a broad host range (48) . In the present study, the MLS B resistance genes erm(A) and erm(B), the partial nucleotide sequence of the tra gene regions, and an -ε-toxin-antitoxin module were observed in all three partially sequenced conjugative plasmids. This suggested that the 4,447-bp central region with the cfr gene and two ISEnfa4 elements had integrated into a pAM␤1-like backbone. A closer look at the sequences identified two integration sites. We propose that the 4,447-bp central region in pW9-2 has integrated into the coding sequence of AM16 via sample transposition; while in pW3 and p3-38, this element probably integrated into the region between the AM15 and AM17 genes, most likely by homologous recombination. The PCR-based stability tests also revealed that the cfr gene and one ISEnfa4 copy can easily be excised, suggesting that this multiresistance gene may also be transferable via ISEnfa4-mediated recombination.
With the exception of the multiresistance gene cfr, the MLS B genes erm(A) or erm(B) have also been found in three conjugative plasmids in our study. The coexistence of MLS B genes and cfr in the same plasmid will allow for persistence and coselection of the cfr gene under the positive selective pressure imposed by the use of macrolides, such as tylosin and tilmicosin. The macrolides, as well as a number of other classes of antimicrobials, including ampicillin, florfenicol, trimethoprim-sulfamethoxazole, lincomycin, and tiamulin, have been used for curing or preventing bacterial infections in three of the pig farms investigated here, according to the antibiotic usage records of these farms. The persistence of the cfr-carrying plasmids among enterococci identified here may also be attributed to the coexistence of -ε-toxin-antitoxin module, which is known to promote the persistence of plasmids by encod- ing a system that kills or prevents the growth of plasmid-free cells (49) . Therefore, the potential threat that the accumulation of multiple resistance genes including cfr on a plasmid with a toxinantitoxin module poses is of great concern.
In conclusion, the data presented here described three conjugative plasmids carrying the multiresistance gene cfr in enterococci from pigs and their surrounding environments. The cfrcarrying center region flanked by the ISEnfa4 elements in these conjugative plasmids harboring tra regions and toxin-antitoxin systems is a potential risk factor for dissemination of this multiresistance gene among enterococci isolates and possibly other species of Gram-positive bacteria, which many believe cause a threat to public health.
